Responses
Poster sessions
Idiopathic pulmonary fibrosis boldly goes where no disease has gone before
P13 Safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Integrated analysis of cumulative data from 5 clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.